3 Einträge gefunden

1. The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithm of the 2017 ESC consensus statement: a simulation study in a contemporary CAD cohort

   1. Blaum, Christopher
   2. Seiffert, Moritz
   3. Goßling, Alina
   4. Kröger, Friederike
   5. Bay, Benjamin
   6. Lorenz, Thiess
   7. Braetz, Julian

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Target Populations and Treatment Cost for Bempedoic Acid and PCSK9 Inhibitors: A Simulation Study in a Contemporary CAD Cohort

   1. Blaum, Christopher
   2. Brunner, Fabian J
   3. Goßling, Alina
   4. Kröger, Friederike
   5. Bay, Benjamin
   6. Lorenz, Thiess
   7. Graef, Annika

   2021 - Forschungsinformationssystem des UKE
3. Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population

   1. Blaum, Christopher
   2. Brunner, Fabian J
   3. Kröger, Friederike
   4. Braetz, Julian
   5. Lorenz, Thiess
   6. Goßling, Alina
   7. Ojeda, Francisco

   2021 - Forschungsinformationssystem des UKE - frei zugänglich